Abstract:Neuroinflammation is considered to be a significant mechanism contributing to depression. Several studies have reported that A1 astrocytes were highly prevalent in human neuroinflammatory and neurodegenerative diseases. However, the precise mechanism by which A1 astrocytes contribute to depression remains unclear. Clinical studies have suggested a correlation between TNF-α, an activator of A1 astrocytes, and the severity of depression. Based on these findings, we hypothesized that TNF-α might worsen depression by activating A1 astrocytes. Our previous studies indicated that Rhodomyrtone (Rho) has the potential to improve depression-like behavior in mice. However, the exact mechanism for this effect has not been fully elucidated. Importantly, it was reported that Rho alleviated skin inflammation in a mouse model of psoriasis by inhibiting the expression of TNF-α. Based on this finding, we hypothesized that rhodomyrtone may exert antidepressant effects by modulating the TNF-α pathway. However, further research is required to investigate and validate these hypotheses, shedding light on the relationships between neuroinflammation, A1 astrocytes, TNF-α, and depression. By obtaining a deeper understanding of the underlying mechanisms, these findings could lead to the development of novel antidepressant strategies that target the TNF-α pathway in the context of neuroinflammation. In vivo, based on the established chronic unpredictable mild stress (CUMS) mouse depression model, we characterized the mechanism of TNF-α and Rho during depression by using several behavioral assays, adeno-associated virus(AAV) transfection, western blotting, immunofluorescence, and other experimental methods. In vitro, we characterized the effect of Rho on inflammation in TNF-α-treated primary astrocytes. TNFR1 expression was significantly increased in the hippocampus of depression-like mice, with increased astrocytes activation and neuronal apoptosis. These processes were further enhanced with increasing levels of TNF-α in the cerebrospinal fluid of mice. However, this process was attenuated by knockdown of TNFR1 and infliximab (Inf; a TNF-α antagonist). Injection of rhodomyrtone decreased the expressions of TNFR1 and TNF-α, resulting in significant improvements in mouse depression-like behaviors and reduction of astrocyte activation. TNF-α could be involved in the pathophysiological process of depression, through mediating astrocytes activation by binding to TNFR1. By blocking this pathway, Rho may be a novel antidepressant.

Deficiency of astrocyte CysLT 1 R ameliorates depression-like behaviors in mice by modulating glutamate synaptic transmission

Microglial Glutaminase 1 Deficiency Mitigates Neuroinflammation Associated Depression.

Microglial glutaminase 1 mediates chronic restraint stress-induced depression-like behaviors and synaptic damages

Glutamate Transporter 1-Mediated Antidepressant-Like Effect in a Rat Model of Chronic Unpredictable Stress

High-frequency repetitive transcranial magnetic stimulation improves depressive-like behaviors in CUMS-induced rats by modulating astrocyte GLT-1 to reduce glutamate toxicity

A1 astrocytes contribute to murine depression-like behavior and cognitive dysfunction, which can be alleviated by IL-10 or fluorocitrate treatment

Cytisine, a Partial Agonist of Α4β2 Nicotinic Acetylcholine Receptors, Reduced Unpredictable Chronic Mild Stress-Induced Depression-Like Behaviors

The role of astrocytes in depression, its prevention, and treatment by targeting astroglial gliotransmitter release

Reduced astrocytic mGluR5 in the hippocampus is associated with stress-induced depressive-like behaviors in mice

Astrocyte ezrin defines resilience to stress-induced depressive behaviours in mice

TNF-α/TNFR1 activated astrocytes exacerbate depression-like behavior in CUMS mice

Atractylenolide I Suppresses A1 Astrocyte Activation to Improve Depression in Mice

Astrocytic lactate dehydrogenase A regulates neuronal excitability and depressive-like behaviors through lactate homeostasis in mice

Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole

Microglial NLRP3 Inflammasome Activates Neurotoxic Astrocytes in Depression-Like Mice

Astrocytic ALKBH5 in stress response contributes to depressive-like behaviors in mice

NMDAR (2C) deletion in astrocytes relieved LPS-induced neuroinflammation and depression

Chronic Unexpected Mild Stress Destroys Synaptic Plasticity of Neurons Through a Glutamate Transporter, GLT-1, of Astrocytes in the Ischemic Stroke Rat

C3aR in the medial prefrontal cortex modulates the susceptibility to LPS-induced depressive-like behaviors through glutamatergic neuronal excitability

Does Decreased Autophagy and Dysregulation of LC3A in Astrocytes Play a Role in Major Depressive Disorder?

The Protective Role of Hippocampal LRP1 Knockdown Involves Synaptic Plasticity Through the Promoting Microtubule Dynamics and Activation of Akt/GSK-3β Pathway in Depressive Rats